MATTHEWS JUDITH M. (Chief Financial Officer) sold 36.6% of their position (47.13K shares) of ITERUM THERAPEUTICS PLC on the open market
Open‑market sale worth $17.9K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/15/2022ACC: 0001209191-22-018864
Officer· Chief Financial Officer
Since Feb 2019
-47.13K
Net shares
Net seller
$17.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
100K acquired · 147.13K disposed
Non-Derivative Transactions2
Ordinary Shares
Direct
Shares
+100K
Price / share
—
Trade value
—
% of position
349.3%
3/11/2022
28.63K→128.63K
Ordinary Shares
Direct
Shares
−47.13K
Price / share
$0.38
Trade value
$17.91K
% of position
36.6%
3/14/2022
128.63K→81.50K
Total
Net shares
+52.87K
Net value
-$17.91K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 3/11/2022 | A · Award | +100K | — | — | 349.3% | 28.63K | 128.63K |
| Ordinary Shares Direct | 3/14/2022 | S · Sale | −47.13K | $0.38 | $17.91K | 36.6% | 128.63K | 81.50K |
| Total | +52.87K | -$17.91K | ||||||
Derivative Transactions1
Restricted Share Units
Direct
Converts to
Ordinary Shares
100K shares
Shares
−100K
Strike price
Held after
100K
Exercisable
—
3/11/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Share Units Direct | Ordinary Shares100K shares | 3/11/2022 | M · Option Exercise | −100K | — | 100K |